A1RG34:BVMF
Argenx Se Bdr
R$Â 183.73
0.00%
(0.00) Siku 1
5 Okt, 16:02:32 GMT -3 · BRL
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya A1RG34...
Mtaji wa soko
58.79B
Wastani wa kiasi cha mauzo
57.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
R$Â 213.15
Chini kwa wiki 52
R$Â 143.22
Hisa za wawekezaji
62.56M
Idadi ya wafanyakazi
elfu 2
Mtaji wa soko
58.79B
Wastani wa kiasi cha mauzo
57.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
R$Â 213.15
Chini kwa wiki 52
R$Â 143.22
Hisa za wawekezaji
62.56M
Idadi ya wafanyakazi
elfu 2
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
AD HOC NEWS
·
saa 5 zilizopita
Goldman Sachs raises Argenx target to EUR 982: Argenx stock gains 1.50 percent
AD HOC NEWS
·
saa 19 zilizopita
Argenx stock gets fresh VYVGART data before Q3 results
AD HOC NEWS
·
siku 1 iliyopita
argenx presents Vyvgart data: Goldman lifts argenx stock target to EUR 982.00
Yahoo Finance
·
siku 1 iliyopita
10 Wall Street Analysts Think Argenx Stock Is Headed to At Least $1,200 -- Is the Stock a Buy Now?
Wasifu
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
Kuhusu Argenx Se Bdr
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 1.86
Lilianzishwa25 Apr 2008
Makao makuu-
Sekta-
Tovutiargenx.com